CVS Health’s announced separation into two public companies could give its retail arm more room to spotlight beauty and wellness products.
Key points
- CVS intends to split into CVS Pharmacy and a health‑care solutions company by early 2028, creating two separate public entities.
- The separation could give the retail arm greater freedom to prioritize beauty and wellness, potentially improving margins and shopper intimacy.
- Current merchandising initiatives already emphasize beauty, but the ultimate impact will depend on how the new CVS Pharmacy allocates capital and space to these categories.
CVS Health disclosed that it will divide into two independent, publicly traded entities – a retail pharmacy business and a health‑care solutions company – with the split slated for the first half of 2028, subject to standard regulatory approvals.
The retail side, to be called CVS Pharmacy, will encompass roughly 9,000 stores, a mail‑order pharmacy, MinuteClinic clinics and the Health100 technology service, and Prem Shah, currently group president of CVS Health, is set to become its chief executive.
Corporate split timeline
Industry observers see the separation as an opportunity for the retailer to sharpen its front‑end sales. Wendy Liebmann, CEO of WSL Strategic Retail, said the move lets CVS “focus on retail, and health and beauty are core category pillars,” while Rohit Banota of Jump Accelerator noted that a stand‑alone retail company could better target high‑margin beauty offerings through personalized technology and curated experiences.
CVS leadership also framed the split as a way to increase agility. David Joyner, chairman and CEO of CVS Health, told investors that each company will have “greater flexibility to adopt the technologies that best fit its needs, improve efficiency and more effectively adapt to regulatory dynamics.” Jeffrey Ten cautioned that the real test will be whether beauty becomes a growth engine or merely a margin backstop, expecting tighter pressure on productivity per square foot and assortment rationalisation.
Potential boost for beauty and wellness
Recent merchandising changes already hint at a stronger beauty focus. Under Michelle LeBlanc, vice president of merchandising for beauty, personal care and the Hispanic Strategy Team, CVS has moved skin‑care to prominent locations, simplified assortments and localized product selections. Grouping all men’s brands together reportedly generated triple‑digit growth, and the retailer now has beauty advisers in about 700 stores. CVS also sees an opportunity to cross‑sell health‑focused products to customers using GLP‑1 medications, who tend to spend more on beauty and wellness items.
Analysts suggest that if the split proceeds as planned, CVS Pharmacy could invest further in front‑of‑store experiences, exclusive product lines and hyper‑personalised technology, positioning beauty and wellness as key drivers of traffic and margin.
Reader questions
When is the CVS split expected to be completed?
The company aims to finish the separation in the first half of 2028, pending customary regulatory approvals.
Who will lead the new CVS Pharmacy after the split?
Prem Shah, currently group president of CVS Health, is slated to become CEO of CVS Pharmacy.
Source: wwd.com
